Mergers & Acquisitions - Cardio-vascular, Pharmaceutical

Filter

Popular Filters

Retrophin to acquire Manchester Pharma in $62.5 million deal

Retrophin to acquire Manchester Pharma in $62.5 million deal

13-02-2014

USA-based Retrophin has signed an agreement to acquire Manchester Pharmaceuticals, a privately-held specialty…

Cardio-vascularChenodalManchester PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesRetrophinVecamyl

Oxygen Biotherapeutics signs agreement to acquire Phase III cardiac drug from Phyxius Pharma

22-10-2013

US drug developer Oxygen Biotherapeutics has signed a Definitive Agreement to acquire certain assets…

Cardio-vascularLevosimendanLicensingMergers & AcquisitionsNorth AmericaOxygen BiotherapeuticsPharmaceutical

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

XOMA transfers perindopril franchise rights to Symplmed

08-07-2013

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has transferred US development and commercialization…

Cardio-vascularLicensingMergers & AcquisitionsperindoprilPharmaceuticalServierSymplmedXOMA Corp

Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site

19-06-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

AstraZeneca to buy Omthera in up to $443 million deal

28-05-2013

Anglo-Swedish drug major AstraZeneca's (LSE: AZN) new chief executive Pascal Soriot is making another…

AstraZenecaCardio-vascularEpanovaMergers & AcquisitionsOmthera PharmaceuticalsPharmaceutical

AstraZeneca acquires AlphaCore; Merck Serono links with BioMed X

03-04-2013

In line with its stated policy of targeted acquisitions, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlphaCore PharmaAstraZenecaBiotechnologyCardio-vascularMerck KGaAMerck SeronoMergers & AcquisitionsMetabolicsPharmaceuticalResearch

Bayer's Xarelto gets EU clearance for PE and prevention of DVT; gives up on Schiff acquisition

21-11-2012

Following swiftly on similar news from the US Food and Drug Administration, German drug major Bayer (BAYN:…

BayerCardio-vascularEuropeJanssenJohnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationSchiff Nutrition InternationalXarelto

Janssen buys Germany's CorImmun

29-06-2012

US health care giant Johnson & Johnson's (NYSE: JNJ) European subsidiary Janssen-Cilag GmbH yesterday…

Cardio-vascularCorImmun GmbHJanssenJohnson & JohnsonMergers & AcquisitionsPharmaceutical

Cornerstone makes $125 million, plus, bid for EKR Thera

16-05-2012

In a second acquisition move within a matter of months, USA-based specialty drugmaker Cornerstone Therapeutics…

Cardio-vascularCornerstone TherapeuticsEKR TherapeuticsMergers & AcquisitionsPharmaceutical

J&J's Janssen files Xarelto with FDA for new indication; buys Chinese firm

03-05-2012

US health care major Johnson & Johnson's (NYSE: JNJ) subsidiary Janssen Research & Development says it…

Asia-PacificBayerBioseal BiotechBiotechnologyCardio-vascularJanssenJohnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationXarelto

Mylan gets OK for generic Crestor in Canada; Rottapharm deal looks dead

18-03-2012

The Canadian subsidiary of US generic drugmaker Mylan (Nasdaq: MYL) has received approval from Health…

AstraZenecaCardio-vascularCrestorEuropeGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaPharmaceuticalRegulationRottapharm

Lundbeck buys remaining rights to desmoteplase from Paion

29-02-2012

Danish CNS drug specialist Lundbeck A/S (LUND: DC) and Germany’s Paion AG (FSE: PA8) have entered…

Cardio-vasculardesmoteplaseLundbeckMergers & AcquisitionsPaionPharmaceutical

Karo Bio drops eprotirome and split up plans

15-02-2012

There was a double-dose of bad news for Sweden’s Karo Bio (STO: KARO), which this week said it would…

BiotechnologyCardio-vasculareprotiromeKaro BioMergers & AcquisitionsPharmaceuticalRegulation

Hikma adds to stake in Promopharm; gets US appro for argatroban

22-01-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

XOMA acquires US rights to perindopril franchise

18-01-2012

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has acquired US rights to the perindopril franchise…

AceonCardio-vascularMergers & AcquisitionsperindoprilPharmaceuticalServierXOMA Corp

Cornerstone acquires Cardiokine

04-01-2012

US specialty drugmaker Cornerstone Therapeutics (Nasdaq: CRTX) said yesterday that it has acquired Cardiokine,…

Cardio-vascularCardiokineCornerstone TherapeuticslixivaptanMergers & AcquisitionsMetabolicsPharmaceutical

Back to top